Skip to content

Percutaneous Needle Electrolysis Versus Surgery in the Treatment of Carpal Tunnel Syndrome

Percutaneous Needle Electrolysis Versus Surgery in the Treatment of Carpal Tunnel Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04216147
Enrollment
140
Registered
2020-01-02
Start date
2015-12-01
Completion date
2019-01-31
Last updated
2020-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Keywords

carpal tunnel syndrome, nerve compression syndrome, median nerve, physical therapy technique, percutaneous needle electrolysis

Brief summary

The aim of this study is to compare the effectiveness of Percutaneous Needle Electrolysis (PNE) versus surgical treatment in the treatment of Carpal Tunnel Syndrome (CTS).

Interventions

OTHERPNE

Percutaneous Needle Electrolysis: the application of galvanic current through an acupuncture needle.

PROCEDURESurgery for CTS

Median nerve release

Sponsors

Universidad de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years. * CTS diagnosed by Electromyography (EMG) * Symptoms of CTS + EMG

Exclusion criteria

* Difficulty expressing your feelings properly * Unsurpassed fear of needles * History of adverse reactions to needles * Epilepsy and / or allergies to metals. * Difficulty expressing your feelings properly * Existence of diffuse peripheral neuropathy or cervical radiculopathy * History of potential concurrent cause of idiopathic CTS (such as diabetes, thyroid, chronic rheumatoid arthritis, renal failure with hemodialysis, pregnancy..)

Design outcomes

Primary

MeasureTime frameDescription
Changes of the Boston Questionnaire for Carpal Tunnel SyndromeBaseline and after treatments: 6 weeks, 3 months, 6 months and 12 months11-question patient-administered survey that rates the severity of the patient's carpal tunnel syndrome-specific symptoms on a scale of 1 (no symptoms) to 5 (worst symptoms)

Secondary

MeasureTime frameDescription
Changes of the Clinical Symptoms Carpal Tunnel Syndrome ScaleBaseline and after treatments: 6 weeks, 3 months, 6 months and 12 monthsDescribe the symptoms of the hand and wrist (pointing to them in a drawing), and using scales of 1 to 5 (1= No difficulty to do it; 5= I can´t do it), measure the difficulty of performing certain activities (writing, buttoning, holding a book ...)
Change of pain levelBaseline and after treatments: 6 weeks, 3 months, 6 months and 12 monthsVisual Analogue Scale (VAS: 0=no pain; 100= pain as bad as can be)
Change of Semmes Weinstein Mini monofilament kitBaseline and after treatments: 6 weeks, 3 months, 6 months and 12 monthsContact threshold, to assess if there is a decrease in sensitivity
Change of the Hand DynamometerBaseline and after treatments: 6 weeks, 3 months, 6 months and 12 monthsHand grip force
Changes of the Muscles strength by Kendall´s scaleBaseline and after treatments: 6 weeks, 3 months, 6 months and 12 monthsMuscular strength of Opponens pollicis and Abductors policies. Scale of 0 to 5 (0=No visible or palpable contraction; 5=Full ROM against gravity, maximum resistance)
Changes of the SF-12 Questionnaire (Short Form 12 Questionnaire)Baseline and after treatments: 6 weeks, 3 months, 6 months and 12 months12 questions self-administered. Assess quality of life, general health and well-being using scales of 1 to 5 (1= Ever; 5= Never)

Other

MeasureTime frameDescription
Direct and indirect health cost measures12 months after treatmentsNumber of visits to the specialist, number of hospitalization days, number of physiotherapy sessions, prescribed medication, days of work absenteeism

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026